Development of 6′-N-acylated isepamicin analogs with improved antibacterial activity against isepamicin-resistant pathogens

Yeon Hee Ban; Myoung Chong Song; Hee Jin Kim; Heejeong Lee; Jae Bok Wi; Je Won Park; Dong Gun Lee; Yeo Joon Yoon

doi:10.3390/biom10060893

Development of 6′-N-acylated isepamicin analogs with improved antibacterial activity against isepamicin-resistant pathogens

Yeon Hee Ban
, Myoung Chong Song
, Hee Jin Kim
, Heejeong Lee
, Jae Bok Wi
, Je Won Park
, Dong Gun Lee
, Yeo Joon Yoon

Seoul National University
Ewha Womans University
Kyungpook National University
Korea University

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

The development of new aminoglycoside (AG) antibiotics has been required to overcome the resistance mechanism of AG-modifying enzymes (AMEs) of AG-resistant pathogens. The AG acetyltransferase, AAC(6′)-APH(2″), one of the most typical AMEs, exhibiting substrate promiscuity towards a variety of AGs and acyl-CoAs, was employed to enzymatically synthesize new 6′-N-acylated isepamicin (ISP) analogs, 6′-N-acetyl/-propionyl/-malonyl ISPs. They were all active against the ISP-resistant Gram-negative bacteria tested, and the 6′-N-acetyl ISP displayed reduced toxicity compared to ISP in vitro. This study demonstrated the importance of the modification of the 6′-amino group in circumventing AG-resistance and the potential of regioselective enzymatic modification of AG scaffolds for the development of more robust AG antibiotics.

Original language	English
Article number	893
Pages (from-to)	1-11
Number of pages	11
Journal	Biomolecules
Volume	10
Issue number	6
DOIs	https://doi.org/10.3390/biom10060893
State	Published - Jun 2020

Keywords

6′-N-acylation
Antibacterial activity
Cytotoxicity
Enzymatic synthesis
Isepamicin analogs

Access to Document

10.3390/biom10060893

Cite this

@article{8cb254b25d474605ae105aba27178f5d,

title = "Development of 6′-N-acylated isepamicin analogs with improved antibacterial activity against isepamicin-resistant pathogens",

abstract = "The development of new aminoglycoside (AG) antibiotics has been required to overcome the resistance mechanism of AG-modifying enzymes (AMEs) of AG-resistant pathogens. The AG acetyltransferase, AAC(6′)-APH(2″), one of the most typical AMEs, exhibiting substrate promiscuity towards a variety of AGs and acyl-CoAs, was employed to enzymatically synthesize new 6′-N-acylated isepamicin (ISP) analogs, 6′-N-acetyl/-propionyl/-malonyl ISPs. They were all active against the ISP-resistant Gram-negative bacteria tested, and the 6′-N-acetyl ISP displayed reduced toxicity compared to ISP in vitro. This study demonstrated the importance of the modification of the 6′-amino group in circumventing AG-resistance and the potential of regioselective enzymatic modification of AG scaffolds for the development of more robust AG antibiotics.",

keywords = "6′-N-acylation, Antibacterial activity, Cytotoxicity, Enzymatic synthesis, Isepamicin analogs",

author = "Ban, \{Yeon Hee\} and Song, \{Myoung Chong\} and Kim, \{Hee Jin\} and Heejeong Lee and Wi, \{Jae Bok\} and Park, \{Je Won\} and Lee, \{Dong Gun\} and Yoon, \{Yeo Joon\}",

note = "Publisher Copyright: {\textcopyright} 2020 by the authors. Licensee MDPI, Basel, Switzerland.",

year = "2020",

month = jun,

doi = "10.3390/biom10060893",

language = "English",

volume = "10",

pages = "1--11",

journal = "Biomolecules",

issn = "2218-273X",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "6",

}

TY - JOUR

T1 - Development of 6′-N-acylated isepamicin analogs with improved antibacterial activity against isepamicin-resistant pathogens

AU - Ban, Yeon Hee

AU - Song, Myoung Chong

AU - Kim, Hee Jin

AU - Lee, Heejeong

AU - Wi, Jae Bok

AU - Park, Je Won

AU - Lee, Dong Gun

AU - Yoon, Yeo Joon

PY - 2020/6

Y1 - 2020/6

N2 - The development of new aminoglycoside (AG) antibiotics has been required to overcome the resistance mechanism of AG-modifying enzymes (AMEs) of AG-resistant pathogens. The AG acetyltransferase, AAC(6′)-APH(2″), one of the most typical AMEs, exhibiting substrate promiscuity towards a variety of AGs and acyl-CoAs, was employed to enzymatically synthesize new 6′-N-acylated isepamicin (ISP) analogs, 6′-N-acetyl/-propionyl/-malonyl ISPs. They were all active against the ISP-resistant Gram-negative bacteria tested, and the 6′-N-acetyl ISP displayed reduced toxicity compared to ISP in vitro. This study demonstrated the importance of the modification of the 6′-amino group in circumventing AG-resistance and the potential of regioselective enzymatic modification of AG scaffolds for the development of more robust AG antibiotics.

AB - The development of new aminoglycoside (AG) antibiotics has been required to overcome the resistance mechanism of AG-modifying enzymes (AMEs) of AG-resistant pathogens. The AG acetyltransferase, AAC(6′)-APH(2″), one of the most typical AMEs, exhibiting substrate promiscuity towards a variety of AGs and acyl-CoAs, was employed to enzymatically synthesize new 6′-N-acylated isepamicin (ISP) analogs, 6′-N-acetyl/-propionyl/-malonyl ISPs. They were all active against the ISP-resistant Gram-negative bacteria tested, and the 6′-N-acetyl ISP displayed reduced toxicity compared to ISP in vitro. This study demonstrated the importance of the modification of the 6′-amino group in circumventing AG-resistance and the potential of regioselective enzymatic modification of AG scaffolds for the development of more robust AG antibiotics.

KW - 6′-N-acylation

KW - Antibacterial activity

KW - Cytotoxicity

KW - Enzymatic synthesis

KW - Isepamicin analogs

UR - https://www.scopus.com/pages/publications/85086621908

U2 - 10.3390/biom10060893

DO - 10.3390/biom10060893

M3 - Article

C2 - 32545254

AN - SCOPUS:85086621908

SN - 2218-273X

VL - 10

SP - 1

EP - 11

JO - Biomolecules

JF - Biomolecules

IS - 6

M1 - 893

ER -

Development of 6′-N-acylated isepamicin analogs with improved antibacterial activity against isepamicin-resistant pathogens

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this